23:24 , Apr 6, 2017 |  BC Extra  |  Company News

Management tracks

Sanofi (Euronext:SAN; NYSE:SNY) said David Meeker will resign as EVP of its Sanofi Genzyme unit at the end of June. The company promoted Bill Sibold to the position, effective July 1. Sibold is head of...
07:00 , Oct 24, 2016 |  BioCentury  |  Finance

Eyes on Spain

Ysios Capital Partners kept the doors open for its second fund longer than expected to welcome a new crop of deep-pocketed LPs who took interest in the firm’s latest investments. Ysios BioFund II Innvierte launched...
07:00 , Oct 18, 2016 |  BC Extra  |  Financial News

Ysios closes EUR 126.4M fund

Spanish venture firm Ysios Capital Partners closed its second fund, Ysios BioFund II Innvierte, with EUR 126.4 million ($138.7 million). The raise was above its EUR 100 million ($109.8 million) target (see BioCentury Extra, March...
08:00 , Jan 18, 2016 |  BC Week In Review  |  Financial News

Aelix Therapeutics completes venture financing

Aelix Therapeutics S.L., Barcelona, Spain   Business: Infectious   Date completed: 2016-01-11   Type: Venture financing   Raised: EUR11.5 million ($12.5 million)   Investors: Ysios Capital Partners; Johnson & Johnson Development Corp.; Caixa Capital   ...
02:45 , Jan 12, 2016 |  BC Extra  |  Financial News

Aelix raises EUR 11.5M in series A

HIV vaccine developer Aelix Therapeutics S.L. (Barcelona, Spain) raised EUR 11.5 million ($12.5 million) in a series A round led by Ysios Capital. The Johnson & Johnson Innovation-JJDC venture arm of Johnson & Johnson (NYSE:JNJ)...